Reported results
- Q3 2026 net sales were $496.4 million compared to $456.2 million in Q3 2025.
- Q3 2026 GAAP diluted net income per common share was $0.50 compared to $0.26 in Q3 2025.
- Q3 2026 adjusted diluted net income per share was $0.50 compared to $0.37 in Q3 2025.
- Q3 2026 GAAP operating income was $54.8 million compared to $36.0 million in Q3 2025.
- Q3 2026 non-GAAP adjusted operating income was $54.4 million compared to $44.8 million in Q3 2025.
Guidance
- 2026 sales of $2.025 billion to $2.125 billion
- 2026 adjusted diluted earnings per share of $2.30 to $2.40
- 2026 free cash flow of greater than $195 million
- 2026 capital expenditures less than $100 million
Notes
The company reported restructuring charges related to the shutdown of industrial-oriented manufacturing at the Leicester, UK facility and non-recurring professional fees in 2026; 2025 results included charges for the divestiture of the Neumarkt, Austria business, closure of the Welkenraedt, Belgium facility, and divestiture of the Hartford, Connecticut business.
Price and volatility reaction
The stock moved -9.5% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -5.1 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 89.84 | 2026-10-21 |
| Close after release | 81.27 | 2026-10-22 |
| Realised move | -9.5% | close to close |
| 30d ATM IV change | -5.1 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-21 (8-K, Item 2.02). Read the original filing on sec.gov.
